Chloroquine interferes with lipopolysaccharide-induced TNF-α gene expression by a nonlysosomotropic mechanism

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1534-1540

  Weber, Stephen M ^a   Levitz, Stuart M ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Section of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; CHLOROQUINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEPACRINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DOSE RESPONSE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALARIA; PRIORITY JOURNAL; RHEUMATIC DISEASE;

EID: 0034254555     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1534     Document Type: Article

References (56)

1. O'Neill, P. M., P. G. Bray, S. R. Hawley, S. A. Ward, and B. K. Park. 1998. 4-Aminoquinolines - past, present, and future: a chemical perspective. Pharmacol. Ther. 77:29.
2. van Es, H. H., H. Renkema, H. Aerts, and E. Schurr. 1994. Enhanced lysosomal acidification leads to increased chloroquine accumulation in CHO cells expressing the pfmdr1 gene. Mol. Biochem. Parasitol. 68:209.
3. French, J. K., N. P. Hurst, M. L. O'Donnell, and W. H. Betts. 1987. Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann. Rheum. Dis. 46:42.
4. Broll, H. 1983. Effect of chloroquine diphosphate on the superhelix structure of DNA and protein synthesis in synovial cells in chronic polyarthritis. Wien. Klin. Wochenschr. 95:877.
5. Jeong, J. Y., and D. M. Jue. 1997. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages. J. Immunol. 158:4901.
6. Sewell, R. B., S. S. Barham, and N. F. LaRusso. 1983. Effect of chloroquine on the form and function of hepatocyte lysosomes: morphologic modifications and physiologic alterations related to the biliary excretion of lipids and proteins. Gastroenterology 85:1146.
7. Kwakye-Berko, F., and S. R. Meshnick. 1989. Binding of chloroquine to DNA. Mol. Biochem. Parasitol. 35:51.
8. Bottger, B. A., M. Sjolund, and J. Thyberg. 1988. Chloroquine and monensin inhibit induction of DNA synthesis in rat arterial smooth muscle cells stimulated with platelet-derived growth factor. Cell Tissue Res. 252:275.
9. Miyachi, Y., A. Yoshioka, S. Imamura, and Y. Niwa. 1986. Antioxidant action of antimalarials. Ann. Rheum. Dis. 45:244.
10. Misra, U. K., G. Gawdi, and S. V. Pizzo. 1997. Chloroquine, quinine and quinidine inhibit calcium release from macrophage intracellular stores by blocking inositol 1,4,5-trisphosphate binding to its receptor. J. Cell. Biochem. 64:225.
11. Kalisz, H., G. Pohlig, and H. Holzer. 1987. Inhibition of protein phosphorylation by chloroquine. Arch. Microbiol. 147:235.
12. Bondeson, J., and R. Sundler. 1998. Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1β and tumor necrosis factor α in macrophages: implications for their mode of action in rheumatoid arthritis. Gen. Pharmacol. 30:357.
13. Picot, S., F. Peyron, A. Donadille, J. P. Vuillez, G. Barbe, and P. Ambroise-Thomas. 1993. Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism. Immunology 80:127.
14. van den Borne, B. E., B. A. Dijkmans, H. H. de Rooij, S. le Cessie, and C. L. Verweij. 1997. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-α, interleukin 6, and interferon-γ production by peripheral blood mononuclear cells. J. Rheumatol. 24:55.
15. Karres, I., J. P. Kremer, I. Dietl, U. Steckholzer, M. Jochum, and W. Ertel. 1998. Chloroquine inhibits proinflammatory cytokine release into human whole blood. Am. J. Physiol. 274:R1058.
16. Zhu, X., W. Ertel, A. Ayala, M. H. Morrison, M. M. Perrin, and I. H. Chaudry. 1993. Chloroquine inhibits macrophage tumour necrosis factor-α mRNA transcription. Immunology 80:122.
17. Picot, S., F. Peyron, J. P. Vuillez, B. Polack, and P. Ambroise-Thomas. 1991. Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro. J. Infect. Dis. 164:830.
18. Levitz, S. M., S. H. Nong, K. F. Seetoo, T. S. Harrison, R. A. Speizer, and E. R. Simons. 1999. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67:885.
19. Levitz, S. M., A. Tabuni, H. Kornfeld, C. C. Reardon, and D. T. Golenbock. 1994. Production of tumor necrosis factor α in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun. 62:1975.
20. +-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266:17707.
21. Huang, C., and S. M. Levitz. 2000. Stimulation of macrophage inflammatory protein-1α, macrophage inflammatory protein-1β, and RANTES by Candida albicans and Cryptococcus neoformans in peripheral blood mononuclear cells from persons with and without human immunodeficiency virus infection. J. Infect. Dis. 181:791.
22. Levitz, S. M., A. Tabuni, S. H. Nong, and D. T. Golenbock. 1996. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect. Immun. 64:945.
23. + T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin. Exp. Immunol. 105:517.
24. Haziot, A., S. Chen, E. Ferrero, M. G. Low, R. Silber, and S. M. Goyert. 1988. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141:547.
25. Chung, I. Y., J. Kwon, and E. N. Benveniste. 1992. Role of protein kinase C activity in tumor necrosis factor-α gene expression: involvement at the transcriptional level. J. Immunol. 149:3894.
26. Kishore, R., J. M. Tebo, M. Kolosov, and T. A. Hamilton. 1999. Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J. Immunol. 162:2457.
27. Lieberman, A. P., P. M. Pitha, and M. L. Shin. 1990. Protein kinase regulates tumor necrosis factor mRNA stability in virus-stimulated astrocytes. J. Exp. Med. 172:989.
28. Lieberman, A. P., P. M. Pitha, and M. L. Shin. 1992. Poly(A) removal is the kinase-regulated step in tumor necrosis factor mRNA decay. J. Biol. Chem. 267: 2123.
29. Trede, N. S., A. V. Tsytsykova, T. Chatila, A. E. Goldfeld, and R. S. Geha. 1995. Transcriptional activation of the human TNF-α promoter by superantigen in human monocytic cells: role of NF-κB. J. Immunol. 155:902.
30. Collart, M. A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor α transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498.
31. Ziegler-Heitbrock, H. W., T. Sternsdorf, J. Liese, B. Belohradsky, C. Weber, A. Wedel, R. Schreck, P. Bauerle, and M. Strobel. 1993. Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J. Immunol. 151:6986.
32. Ballard, D. W., E. P. Dixon, N. J. Peffer, H. Bogerd, S. Doerre, B. Stein, and W. C. Greene. 1992. The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc. Natl. Acad. Sci. USA 89:1875.
33. Ziegler-Heitbrock, H. W., A. Wedel, W. Schraut, M. Strobel, P. Wendelgass, T. Sternsdorf, P. A. Bauerle, J. G. Haas, and G. Riethmuller. 1994. Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimers. J. Biol. Chem. 269:17001.
34. Beers, M. F. 1996. Inhibition of cellular processing of surfactant protein C by drugs affecting intracellular pH gradients. J. Biol. Chem. 271:14361.
35. Sorensen, S. O., H. B. van den Hazel, M. C. Kielland-Brandt, and J. R. Winther. 1994. pH-dependent processing of yeast procarboxypeptidase Y by proteinase A in vivo and in vitro. Eur. J. Biochem. 220:19.
36. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394.
37. Muzio, M., G. Natoli, S. Saccani, M. Levrero, and A. Mantovani. 1998. The human toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187:2097.
38. Muzio, M., J. Ni, P. Feng, and V. M. Dixit. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278:1612.
39. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D. V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443.
40. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860.
41. De Feo, P., E. Volpi, P. Lucidi, G. Cruciani, F. Santeusanio, G. B. Bolli, and P. Brunetti. 1994. Chloroquine reduces whole body proteolysis in humans. Am. J. Physiol. 267:E183.
42. Blagosklonny, M. V., W. G. An, G. Melillo, P. Nguyen, J. B. Trepel, and L. M. Neckers. 1999. Regulation of BRCA1 by protein degradation. Oncogene 18:6460.
43. Wadgaonkar, R., K. M. Phelps, Z. Haque, A. J. Williams, E. S. Silverman, and T. Collins. 1999. CREB-binding protein is a nuclear integrator of nuclear factor-κB and p53 signaling. J. Biol. Chem. 274:1879.
44. Carter, A. B., M. M. Monick, and G. W. Hunninghake. 1999. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am. J. Respir. Cell Mol. Biol. 20:751.
45. Schroter, H., P. E. Shaw, and A. Nordheim. 1987. Purification of intercalator-released p67, a polypeptide that interacts specifically with the c-fos serum response element. Nucleic Acids Res. 15:10145.
46. Zabel, U., R. Schreck, and P. A. Baeuerle. 1991. DNA binding of purified transcription factor NF-κB. J. Biol. Chem. 266:252.
47. Black, R. A., C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729.
48. Yao, J., N. Mackman, T. S. Edgington, and S. T. Fan. 1997. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells: regulation by Egr-1, c-Jun, and NF-κB transcription factors. J. Biol. Chem. 272: 17795.
49. Huffnagle, G. B., G. B. Toews, M. D. Burdick, M. B. Boyd, K. S. McAllister, R. A. McDonald, S. L. Kunkel, and R. M. Strieter. 1996. Afferent phase production of TNF-α is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157:4529.
50. Street, M., P. S. Coulson, C. Sadler, L. J. Warnock, D. McLaughlin, H. Bluethmann, and R. A. Wilson. 1999. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. J. Immunol. 163:4489.
51. Opal, S. M., and A. S. Cross. 1999. Clinical trials for severe sepsis: past failures, and future hopes. Infect. Dis. Clin. North Am. 13:285.
52. van der Poll, T., and S. J. van Deventer. 1999. Cytokines and anticytokines in the pathogenesis of sepsis. Infect. Dis. Clin. North Am. 13:413.
53. Moreland, L. W., S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann, A. L. Weaver, R. E. Ettlinger, S. Cohen, W. J. Koopman, K. Mohler, et al. 1997. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337:141.
54. Fekade, D., K. Knox, K. Hussein, A. Melka, D. G. Lalloo, R. E. Coxon, and D. A. Warrell. 1996. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor α. N. Engl. J. Med. 335:311.
55. McGuire, W., A. V. Hill, C. E. Allsopp, B. M. Greenwood, and D. Kwiatkowski. 1994. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371:508.
56. Kwiatkowski, D., A. V. Hill, I. Sambou, P. Twumasi, J. Castracane, K. R. Manogue, A. Cerami, D. R. Brewster, and B. M. Greenwood. 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336:1201.